FL Lymphoma
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma (NCT07249905) | ModeX Therapeutics, An OPKO Health Company | 2026-04-13 |
| Evaluate the Safety and Clinical Activity of HH2853 (NCT04390737) | Haihe Biopharma Co., Ltd. | 2020-09-08 |
Track FL Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.